Non-invasive fibrosis markers and transient elastography versus liver biopsy as predictors for end treatment response in chronic HCV patients receiving pegylated interferon and ribavirin

Assessment of fibrosis biomarkers alone and incombination with tissue harmonic imaging versushistopathological fibrosis scoring in patients withchronic HCV infection and /or NASH

Evaluation of fibroscan as a predictor of risk of hepatocellular carcinoma in hepatitis C patients

Evaluation of serum fibrogenicmarkers in relation to histopathological findings inpatients with chronic hepatitis C

Towards a scoring system depending on laboratory and ultrasound findingsfor the detection of hepatic fibrosis in chronic HCV infected patients

Non-invasive prediction of oesophageal varices with FibroScan and Doppler U/S in HCV patients with cirrhosis

Evaluation of endoglin as a non–invasive marker of hepatic fibrosis in chronic hepatitis C patients

Comparative study between liver biopsy versus fibroscan in chronic hepatitis C virus patients

A study of non-invasive method for liver fibrosis and prediction of hepatocellular carcinoma

Biochemical markers of liver fibrosis in HCV patients